Growth Metrics

Novartis Ag (NVS) Cash from Operations (2017 - 2025)

Novartis Ag's Cash from Operations history spans 11 years, with the latest figure at 6664000000.0 for Q2 2025.

  • On a quarterly basis, Cash from Operations rose 36.7% to 6664000000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was 25212000000.0, a 23.66% increase, with the full-year FY2025 number at 19144000000.0, up 8.66% from a year prior.
  • Cash from Operations hit 6664000000.0 in Q2 2025 for Novartis Ag, down from 7140000000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for NVS hit a ceiling of 7140000000.0 in Q4 2024 and a floor of 3576000000.0 in Q2 2023.
  • Historically, Cash from Operations has averaged 5371222222.22 across 5 years, with a median of 5404000000.0 in 2022.
  • Biggest five-year swings in Cash from Operations: decreased 13.7% in 2022 and later soared 36.7% in 2025.
  • Tracing NVS's Cash from Operations over 5 years: stood at 6262000000.0 in 2021, then decreased by 13.7% to 5404000000.0 in 2022, then rose by 20.89% to 6533000000.0 in 2023, then grew by 9.29% to 7140000000.0 in 2024, then decreased by 6.67% to 6664000000.0 in 2025.
  • Business Quant data shows Cash from Operations for NVS at 6664000000.0 in Q2 2025, 7140000000.0 in Q4 2024, and 4875000000.0 in Q2 2024.